Why is the Mesoblast share price on ice today?

Mesoblast is another share placed on pause today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Mesoblast shares are on ice today 
  • The company says it is set to complete a private placement 
  • The Mesoblast share price is down 54% for the last 12 months 

The Mesoblast Limited (ASX: MSB) share price is on pause following a company requested halt to trading of its securities.

The ASX granted the company's request before market open today. Prior to being put on ice, the Mesoblast share price closed yesterday's session at 93 cents apiece.

A dollar sign embedded in ice, indicating a share price freeze or trading halt

Image source: Getty Images

Why is the Mesoblast share price frozen?

It appears the company is gearing up to raise additional capital from equity investors.

In the release, it said it "requests a trading halt in its securities effective immediately pending an announcement…in relation to a proposed private placement."

It is not yet understood what the capital raise is for, or what amount the company is seeking to raise from investors.

However, it intends to make the impending announcement between now and 8 August, when the trading halt will then be lifted.

Mesoblast shares have caught a bid lately and are now up more than 36% over the past month of trading, as seen in the chart below.

This gain is in line with the broad healthcare sector, which has realized similar levels of upside in the new financial year.

TradingView Chart

Despite this, the Mesoblast share price is down 54% for the last 12 months or 34% this year to date

More on Healthcare Shares

Five healthcare workers standing together and smiling.
Healthcare Shares

3 ASX 200 healthcare shares to buy amid sector rout

The experts are backing these stocks for price growth.

Read more »

Researchers and doctors with futuristic 3D hologram overlay for body anatomy or DNA in hospital clinic.
Healthcare Shares

Are investors taking a big gamble chasing 4DX shares higher and higher?

Investor interest in this ASX healthcare tech stock is booming.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

Half a man's face from the nose up peers over a table.
Healthcare Shares

If I could buy only 1 ASX 200 share right now, it would be…

This stock looks underpriced and oversold to me.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

CSL shares slide again in March — but is a comeback brewing?

Brokers remain upbeat and see upside up to 95% for the biotech stock.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
Healthcare Shares

Is it time to get greedy with CSL shares?

This ASX healthcare giant is out of favour, but that may be where opportunity starts.

Read more »

Stressed, unhappy, and tired scientist with a headache working on a computer in a lab.
Healthcare Shares

3 ASX 200 healthcare shares at multi-year lows

Does this present a buying opportunity?

Read more »